News
Hosted on MSN6mon
FDA grants marketing authorisation to Peytant’s AMStent systemPeytant Solutions has received marketing authorisation from the US Food and Drug Administration (FDA) for its AMStent tracheobronchial covered stent system. This novel therapy platform is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results